Cytosorbents (CTSO) Gross Profit Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.74% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 27.39% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -1.74% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.30% |
| 10 | Cytosorbents | 23.04 Mn | 18.24 Mn | 6.13 Mn | -1.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.24% |
| Dec 31, 2025 | 8.78% |
| Sep 30, 2025 | 26.83% |
| Jun 30, 2025 | 4.78% |
| Mar 31, 2025 | -9.70% |
| Dec 31, 2024 | 17.77% |
| Sep 30, 2024 | -6.26% |
| Jun 30, 2024 | 8.05% |
| Mar 31, 2024 | 26.00% |
| Dec 31, 2023 | -7.74% |
| Sep 30, 2023 | 55.00% |
| Jun 30, 2023 | 21.71% |
| Mar 31, 2023 | -14.94% |
| Dec 31, 2022 | -24.84% |
| Sep 30, 2022 | -50.43% |
| Jun 30, 2022 | -46.91% |
| Mar 31, 2022 | -18.27% |
| Dec 31, 2021 | -18.76% |
| Sep 30, 2021 | -4.69% |
| Jun 30, 2021 | 42.30% |